background
acut
bacteri
sinus
frequent
complic
viral
upper
respiratori
infect
uri
describ
clinic
virolog
featur
uri
remain
uncompl
preced
episod
sinus
hypothes
certain
virus
like
lead
acut
sinus
compar
virus
identifi
time
diagnosi
sinus
identifi
earli
uri
method
children
age
month
follow
longitudin
year
nasal
sampl
obtain
surveil
visit
day
uri
day
sinus
diagnos
molecular
diagnost
test
perform
nasal
wash
common
respiratori
virus
pathogen
bacteria
standard
score
use
quantifi
symptom
sever
result
evalu
uri
ill
patient
met
criteria
sinus
respiratori
syncyti
viru
detect
frequent
uri
visit
led
sinus
compar
uncompl
uri
vs
p
new
virus
detect
sinus
episod
pattern
differ
pattern
observ
surveil
median
number
uri
per
subject
per
year
rang
uncompl
uri
subject
rang
sinus
subject
p
conclus
children
develop
sinus
experienc
frequent
uri
compar
children
whose
uri
remain
uncompl
nasal
sampl
obtain
day
diagnosi
acut
sinus
nearli
children
new
viru
identifi
suggest
children
deem
sinus
experienc
sequenti
viral
infect
acut
bacteri
sinus
usual
preced
viral
respiratori
infect
viral
upper
respiratori
infect
uri
caus
mucos
inflamm
within
nose
nasopharynx
promot
obstruct
sinu
ostia
virusinduc
prolifer
pathogen
bacteria
nasopharynx
set
stage
develop
complic
acut
sinus
acut
otiti
media
diagnosi
acut
sinus
made
clinic
criteria
alon
base
presenc
pattern
symptom
differenti
acut
sinus
uncompl
viral
uri
previou
investig
describ
viru
identif
bacteri
colon
asymptomat
children
uncompl
uri
focu
subpopul
children
acut
bacteri
sinus
compar
clinic
virolog
featur
viral
uri
remain
uncompl
preced
episod
sinus
expand
cohort
children
studi
design
test
hypothesi
infect
certain
respiratori
virus
like
predispos
children
acut
sinus
virus
addit
post
hoc
analysi
question
whether
episod
presum
acut
sinus
actual
repres
sequenti
infect
uniqu
virus
conduct
prospect
studi
young
children
includ
monitor
clinic
respiratori
symptom
repeat
collect
sampl
nasal
mucu
analysi
viral
molecular
diagnost
healthi
children
age
month
recruit
throughout
studi
period
pediatr
practic
madison
wisconsin
follow
year
previous
describ
detail
supplementari
method
nasal
sampl
obtain
entri
surveil
visit
children
asymptomat
verifi
studi
nurs
nasal
sampl
also
obtain
day
acut
uri
day
acut
sinus
diagnos
final
recoveri
sampl
retriev
children
uncompl
uri
symptom
complet
resolv
approxim
day
parent
instruct
call
studi
nurs
first
sign
upper
respiratori
ill
symptom
survey
fill
day
subsequ
administ
telephon
day
previous
describ
detail
describ
supplementari
method
respiratori
episod
classifi
either
uncompl
viral
uri
sinus
diagnosi
sinus
base
follow
clinic
criteria
persist
symptomsnas
discharg
cough
boththat
last
day
without
improv
worsen
symptom
evidenc
sudden
renew
respiratori
symptom
nasal
discharg
cough
fever
appar
improv
usual
beyond
sixth
day
ill
radiograph
perform
diagnos
sinus
accord
nation
guidelin
sampl
nasal
mucu
obtain
use
establish
noseblow
techniqu
salin
nasal
solut
spray
child
nostril
studi
nurs
held
plastic
baggi
nose
occlud
nostril
take
care
touch
insid
baggi
child
unabl
blow
nose
suffici
sampl
obtain
allow
spray
salin
drip
plastic
baggi
diagnost
virolog
perform
nasal
sampl
multiplex
polymeras
chain
reaction
pcr
previous
describ
nasal
specimen
also
analyz
partial
sequenc
determin
rhinoviru
type
present
differenti
close
relat
enteroviru
rhinoviru
nasal
sampl
also
analyz
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
use
quantit
realtim
pcr
dna
extract
biostic
bacteremia
dna
isol
kit
mo
bio
laboratori
carlsbad
ca
previous
describ
assay
includ
standard
curv
deriv
bacteria
known
concentr
result
report
colonyform
unit
equivalentsml
cfueml
statist
method
provid
detail
supplementari
materi
studi
period
letter
invit
sent
famili
elig
children
children
exclud
due
underli
condit
patient
enrol
complet
year
followup
supplementari
figur
subject
develop
sinus
similar
demograph
characterist
uncompl
uri
except
slightli
like
report
race
american
indian
alaska
nativ
tabl
report
uri
subject
studi
period
ill
distinct
patient
met
diagnost
criteria
acut
sinus
rate
sinusitiscompl
uri
confid
interv
ci
viru
detect
day
nasal
wash
uncompl
uri
sinus
episod
respect
figur
respiratori
syncyti
viru
rsv
detect
significantli
often
uri
visit
led
sinus
vs
p
distribut
remain
virus
similar
uncompl
uri
sinus
event
virus
detect
uncompl
uri
sinus
visit
respect
p
determin
whether
clinic
characterist
defin
episod
acut
sinus
might
case
caus
sequenti
viral
infect
compar
viral
pcr
perform
nasal
wash
obtain
day
onset
ill
episod
sinus
second
nasal
wash
tenth
day
ill
leav
sinus
event
avail
analysi
case
sinus
diagnos
base
persist
symptom
tabl
nasal
wash
sampl
subject
sinus
compar
obtain
surveil
visit
new
virus
detect
day
like
adenoviru
influenza
respiratori
syncyti
viru
less
like
rhinoviru
comparison
sinus
subject
viru
detect
day
day
show
similar
viru
distribut
observ
surveil
visit
tabl
shown
supplementari
tabl
nasal
bacteri
colon
rate
bacteri
densiti
day
uri
visit
similar
sinus
visit
pneumonia
h
influenza
catarrhali
supplementari
tabl
next
compar
detect
rate
bacteri
pathogen
subject
diagnos
sinus
accord
viru
identifi
sampl
ie
new
viru
vs
neg
viru
absenc
catarrhali
day
p
day
p
appear
risk
factor
acquisit
new
viru
day
tabl
differ
subject
new
viru
neg
viru
sampl
densiti
presenc
pneumonia
h
influenza
either
sampl
rate
uri
subject
uncompl
uri
compar
rate
subject
sinus
median
number
uri
per
subject
per
year
rang
uncompl
uri
subject
rang
sinus
subject
p
figur
test
hypothesi
uri
lead
sinus
would
associ
sever
clinic
symptom
uri
remain
uncompl
symptom
score
compar
day
ill
figur
symptom
score
inde
higher
day
p
day
p
uri
lead
sinus
compar
uncompl
uri
supplementari
tabl
expect
symptom
score
also
significantli
higher
day
definit
determin
individu
symptom
increas
acut
uri
led
sinus
compar
area
curv
day
symptom
supplementari
tabl
congest
cough
nasal
discharg
show
greatest
differ
uncompl
uri
compar
uri
complic
sinus
impair
appetit
sleep
activ
also
significantli
higher
visit
uri
complic
sinus
report
facial
pain
swell
fever
headach
differ
uri
event
consid
day
singl
time
point
greatest
differ
mean
ci
score
symptom
congest
discharg
cough
ci
ci
ci
respect
uri
visit
becam
complic
sinus
ci
ci
ci
respect
uri
visit
remain
uncompl
score
significantli
differ
visit
type
p
symptom
differ
symptom
data
shown
first
studi
describ
clinic
virolog
featur
episod
acut
sinus
compar
uri
popul
children
follow
longitudin
time
period
children
develop
episod
sinus
complic
uri
experienc
frequent
uri
higher
symptom
score
earli
ill
compar
children
whose
uri
remain
uncompl
importantli
nasal
sampl
obtain
day
diagnosi
acut
sinus
nearli
children
new
viru
identifi
differ
pattern
observ
surveil
recoveri
strongli
suggest
children
deem
sinus
actual
experienc
sequenti
viral
uri
rate
complic
uri
sinus
slightli
lower
figur
report
interim
analysi
studi
popul
remain
similar
report
marom
et
al
decreas
may
reflect
effort
last
month
studi
enhanc
report
uri
demonstr
rate
sinus
relat
sever
initi
uri
increas
report
milder
uri
would
expect
result
decreas
rate
complic
studi
rsv
detect
frequent
uri
event
becam
complic
sinus
compar
uncompl
uri
visit
suggest
promin
pathogen
role
viru
although
studi
correl
follow
infant
birth
month
age
perform
viral
pcr
nasopharyng
swab
develop
acut
otiti
media
associ
increas
age
infect
rsv
rhinoviru
enteroviru
bocaviru
although
find
associ
virus
pertin
rsv
associ
complic
studi
rsv
known
elicit
robust
immun
respons
nose
lower
respiratori
tract
probabl
viru
produc
local
inflamm
nasal
mucosa
therebi
affect
sinu
ostia
nation
guidelin
diagnosi
acut
sinus
reli
clinic
criteria
conclud
child
experienc
episod
sinus
persist
respiratori
symptom
day
without
improv
worsen
symptom
period
improv
import
problem
relat
clinic
diagnosi
sinus
persist
worsen
upper
respiratori
symptom
may
result
develop
classic
secondari
bacteri
infect
second
viral
infect
close
space
first
found
use
criteria
persist
worsen
symptom
patient
viru
detect
nasal
sampl
support
diagnosi
bacteri
sinus
patient
howev
nearli
new
viru
identifi
suggest
sequenti
viral
infect
may
explain
symptom
observ
support
data
sever
clinic
trial
demonstr
onethird
children
clinic
diagnos
sinus
lack
evid
bacteri
infect
addit
random
doubleblind
control
trial
placebo
vs
amoxicillinclavulan
acid
children
clinic
diagnos
sinus
nonrespons
rate
antibacteri
spontan
cure
rate
recipi
placebo
correspond
close
percentag
patient
studi
sequenti
viral
infect
also
close
number
children
normal
radiograph
despit
meet
diagnost
criteria
acut
sinus
surveil
sampl
nasal
wash
examin
asymptomat
children
show
presenc
viru
accordingli
although
like
certainti
viru
identifi
day
time
diagnosi
acut
sinus
caus
respiratori
symptom
sinc
asymptomat
detect
common
furthermor
identif
new
viru
preclud
possibl
dual
infect
caus
viru
bacteria
howev
compel
data
show
new
viru
detect
subject
sinus
day
statist
like
adenoviru
influenza
rsv
rather
rhinoviru
compar
virus
identifi
surveil
furthermor
viru
identifi
patient
sinus
day
frequenc
detect
significantli
differ
identif
virus
surveil
recoveri
assess
rel
role
bacteria
viru
visit
compar
bacteri
densiti
nasal
wash
children
viru
new
viru
identifi
use
wash
day
day
categori
categori
found
signific
differ
either
bacteri
presenc
densiti
note
absenc
catarrhali
associ
acquisit
new
viru
contrast
xu
et
al
show
higher
rate
colon
bacteri
pathogen
nasopharynx
otiti
mediapron
children
compar
uncompl
uri
howev
otitispron
children
may
compar
previous
healthi
children
episod
sinus
regard
intens
previou
respiratori
infect
overal
data
support
supposit
patient
diagnos
sinus
use
current
guidelin
new
viru
detect
tenth
day
ill
actual
sequenti
viral
infect
altern
supposit
subject
diagnos
sinus
new
viru
day
new
viral
infect
bacteri
sinus
studi
assess
respons
antimicrobi
necessari
fulli
explor
hypothes
children
develop
sinus
complic
uri
least
studi
time
annual
rate
uri
children
uncompl
uri
may
explain
observ
complet
histolog
recoveri
mucosa
viral
uri
much
slower
clinic
recoveri
therefor
even
mild
infect
could
becom
symptomat
impos
recent
damag
respiratori
mucosa
demonstr
symptom
score
earli
phase
uri
higher
episod
complic
sinus
vs
uncompl
uri
howev
overlap
score
substanti
find
alon
distinguish
patient
uri
go
develop
sinus
strength
studi
includ
larg
sampl
size
multipl
respiratori
season
longitudin
observ
cohort
design
extens
prospect
monitor
symptom
microbiolog
period
well
uri
sinus
limit
studi
includ
narrow
age
rang
year
howev
peak
age
group
children
acut
sinus
avoid
infant
toddler
experi
much
higher
rate
acut
otiti
media
children
acut
otiti
media
like
receiv
antibiot
earlier
uri
could
blunt
appear
sinus
sampl
obtain
use
nasal
wash
may
repres
microbi
condit
nasopharynx
toler
longitudin
studi
repeat
nasopharyng
swab
rate
detect
virus
similar
studi
suggest
thatat
least
virusesthi
method
reliabl
final
despit
substanti
sampl
size
number
children
develop
sinus
rel
small
low
preval
sinus
limit
power
studi
detect
specif
risk
factor
clinic
implic
studi
sinus
may
overdiagnos
use
current
guidelin
viral
pcr
nasal
sampl
feasibl
suffici
exclud
bacteri
sinus
time
clinic
diagnosi
measur
nasal
cytokin
adapt
pointofcar
assay
may
reflect
host
respons
ascrib
viral
infect
acut
bacteri
sinus
common
complic
upper
respiratori
tract
infect
children
studi
support
use
publish
clinic
criteria
diagnosi
acut
sinus
children
distinguish
uncompl
uri
sinus
howev
data
present
provid
preliminari
evid
suggest
children
deem
sinus
instead
experienc
sequenti
viral
infect
supplementari
materi
avail
clinic
infecti
diseas
onlin
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
correspond
author
financi
support
work
support
nation
institut
allergi
infecti
diseas
niaid
nation
institut
health
nih
grant
number
potenti
conflict
interest
j
c
g
receiv
grant
nihniaid
conduct
studi
receiv
person
fee
prep
biopharm
inc
regeneron
medimmun
outsid
submit
work
receiv
support
meissa
vaccin
inc
outsid
submit
work
patent
pend
method
propag
rhinoviru
c
previous
unsuscept
cell
line
adapt
rhinoviru
c
author
report
potenti
conflict
interest
conflict
editor
consid
relev
content
manuscript
disclos
